Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and Haemophilus influenzae carriage in a cross-sectional pediatric cohort in Southampton, UK
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.00224-24 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von David W Cleary und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, Carrier State, SARS-CoV-2, Pneumococcal Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer UK (Pfizer Ltd).
Abstract (Originalsprache)
The Southampton pneumococcal carriage study of children under 5 years old continued during the coronavirus disease 2019 (COVID-19) pandemic. Here, we present data from October 2018 to March 2023 describing prevalence of pneumococci and other pathobionts during the winter seasons before, during, and after the introduction of non-pharmaceutical interventions (NPIs) to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Nasopharyngeal swabs were collected from children attending outpatient clinics at a secondary care hospital and community healthcare sites. Pre-NPIs, in 2019/2020, the carriage prevalence of pneumococci at the hospital site was 32% ( n = 161 positive/499 participants). During NPIs, this fell to 19% ( n = 12/64), although based on fewer participants compared to previous years due to COVID-19 restrictions on health-care attendance. In 2021/2022, after NPIs had eased, prevalence rebounded to 33% ( n = 15/46) [compared to NPIs period, χ 2 (1, N = 110) =2.78, P = 0.09]. Carriage prevalence at community healthcare sites fell significantly from 27% ( n = 127/470) in 2019/2020 to 19% during the NPI period ( n = 44/228) in 2020/2021 [ χ 2 (1, N = 698) =4.95, P = 0.026]. No rebound was observed in 2021/2022 [19% ( n = 56/288)]. However, in a multivariate logistic regression model, neither site had a significantly lower carriage prevalence during the NPI period compared to the post NPI period. A reduction in serotype diversity was observed in 2020/2021. Carriage of Haemophilus influenzae was particularly affected by NPIs with a significant reduction observed. In conclusion, among children under 5 years of age, transient, modest, and statistically non-significant alterations in carriage of both Streptococcus pneumoniae and H. influenzae were associated with SARS-CoV-2 NPIs. IMPORTANCE Streptococcus pneumoniae (the pneumococcus) continues to be a major contributor to global morbidity and mortality. Using our long-running pediatric study, we examined changes in pneumococcal carriage prevalence in nearly 3,000 children under the age of 5 years between the winters of 2018/2019 and 2022/2023. This period coincided with the severe acute respiratory syndrome coronavirus 2 pandemic and, in particular, the implementation of national strategies to limit disease transmission in the UK. We observed a transient reduction of both Streptococcus pneumoniae and Haemophilus influenzae in these populations during this period of non-pharmaceutical interventions. This aligned with the reduction in invasive pneumococcal disease seen in the UK and is therefore a likely contributor to this phenomenon.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
- Vaccines Medical Affairs, Pfizer Ltd, Tadworth, United Kingdom.
- Global Respiratory Vaccines, Scientific and Medical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
- Evidence Generation, Pfizer Inc, Collegeville, Pennsylvania, USA.
- Parasites and Microbes, Wellcome Sanger Institute, Hinxton, United Kingdom.
- Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
ORCID-Profile: David W Cleary, Stephanie W Lo, Stuart C Clarke
Förderung
- Pfizer UK (Pfizer Ltd)
Zitieren
APA
Cleary, D. W., Campling, J., Lahuerta, M., Hayford, K., Southern, J., Gessner, B. D., Lo, S. W., Bentley, S. D., Faust, S. N., & Clarke, S. C. (2024). Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and Haemophilus influenzae carriage in a cross-sectional pediatric cohort in Southampton, UK. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00224-24
Vancouver
Cleary DW, Campling J, Lahuerta M, Hayford K, Southern J, Gessner BD, et al. Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and Haemophilus influenzae carriage in a cross-sectional pediatric cohort in Southampton, UK. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00224-24
BibTeX
@article{Cleary2024,
author = {Cleary, David W and Campling, James and Lahuerta, Maria and Hayford, Kyla and Southern, Jo and Gessner, Bradford D and Lo, Stephanie W and Bentley, Stephen D and Faust, Saul N and Clarke, Stuart C},
title = {Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and Haemophilus influenzae carriage in a cross-sectional pediatric cohort in Southampton, UK},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.00224-24}
}
EUVIMED